FDA finds no problem with heartburn drugs
Prilosec, Nexium don't cause heart risks, according to review
Health care videos |
Health care blues July 10: MSNBC’s Ed Schultz talks with a political panel about why some Blue Dog Democrats are siding with Republicans, threatening to stand in the way of a public option on health care reform. |
INTERACTIVE |
How would you like health care changed? As the government ponders health care reform, what are your top concerns? |
Most popular |
| |||||
WASHINGTON - Patients who suffer from heartburn are not at increased risk for heart problems as a result of taking Prilosec or Nexium, according to a review released Monday by the Food and Drug Administration.
The FDA and its Canadian counterpart began reviewing the drugs, used by tens of millions of people, back in May. The drug's manufacturer, AstraZeneca, provided them with an early analysis of two small studies that suggested the possibility of a risk. The agency said its review of that study as well as 14 others indicated no increased risk for patients.
"FDA recommends that health care providers continue to prescribe, and patients continue to use these products as prescribed," the agency said.
Nexium is the world's No. 2 selling drug, with 2006 sales of $6.7 billion, according to health care research firm IMS Health.
- Discuss Story On Newsvine
-
Rate Story:
View popularLowHigh - Instant Message
MORE FROM HEALTH CARE |
| Add Health care headlines to your news reader: |
Resource guide


